ketamine has been researched along with Amyotrophic Lateral Sclerosis in 3 studies
Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.
Amyotrophic Lateral Sclerosis: A degenerative disorder affecting upper MOTOR NEURONS in the brain and lower motor neurons in the brain stem and SPINAL CORD. Disease onset is usually after the age of 50 and the process is usually fatal within 3 to 6 years. Clinical manifestations include progressive weakness, atrophy, FASCICULATION, hyperreflexia, DYSARTHRIA, dysphagia, and eventual paralysis of respiratory function. Pathologic features include the replacement of motor neurons with fibrous ASTROCYTES and atrophy of anterior SPINAL NERVE ROOTS and corticospinal tracts. (From Adams et al., Principles of Neurology, 6th ed, pp1089-94)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Gold, ND | 1 |
| Mallard, AJ | 1 |
| Hermann, JC | 1 |
| Zeifman, RJ | 1 |
| Pagni, BA | 1 |
| Bogenschutz, MP | 1 |
| Ross, S | 1 |
| Zilio, F | 1 |
| Gomez-Pilar, J | 1 |
| Cao, S | 1 |
| Zhang, J | 1 |
| Zang, D | 1 |
| Qi, Z | 1 |
| Tan, J | 1 |
| Hiromi, T | 1 |
| Wu, X | 1 |
| Fogel, S | 1 |
| Huang, Z | 1 |
| Hohmann, MR | 1 |
| Fomina, T | 1 |
| Synofzik, M | 1 |
| Grosse-Wentrup, M | 1 |
| Owen, AM | 1 |
| Northoff, G | 1 |
| Marcos Vidal, JM | 1 |
| Bermejo González, JC | 1 |
| Baticón Escudero, PM | 1 |
1 review available for ketamine and Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
Exploring the Potential Utility of Psychedelic Therapy for Patients With Amyotrophic Lateral Sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Hallucinogens; Humans; Ketamine; Motor Neuron Disease; Neurodegenerat | 2023 |
2 other studies available for ketamine and Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
Are intrinsic neural timescales related to sensory processing? Evidence from abnormal behavioral states.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Anesthesia, General; Anesthetics, General; Brain; Case-C | 2021 |
[Noninvasive ventilation through a nasal mask to sedate a man with amyotrophic lateral sclerosis during percutaneous endoscopic gastrostomy].
Topics: Amyotrophic Lateral Sclerosis; Apnea; Deep Sedation; Endoscopy; Enteral Nutrition; Gastrostomy; Huma | 2011 |